QuantumBioPharma-Logo-400x400.png
Quantum BioPharma Diversifies Treasury with the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency
December 20, 2024 07:30 ET | Quantum BioPharma
TORONTO, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), is pleased to announce that after receiving approval...
BioTech Breakthrough Awards Badge[1] copy.jpg
Syncell’s Microscoop Winner of BioTech Breakthrough Award For “Proteomics Solution of the Year”
November 21, 2024 20:16 ET | BioTech Breakthrough
TAIPEI, Taiwan and WATERTOWN, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Syncell, a leader in next-generation subcellular protein purification and spatial proteomics analysis, today announced that...
cmi_logo.png
[Latest] Global Pharmaceutical Membrane Filtration Market Size/Share Worth USD 27,620 Million by 2033 at a 13.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
November 21, 2024 12:30 ET | Custom Market Insights
Austin, TX, USA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Pharmaceutical Membrane Filtration Market Size, Trends and Insights By Product...
BioTech Breakthrough Awards Badge[1] copy.jpg
Enrich TROVO Recognized With BioTech Breakthrough’s “Cell Sorting Product of the Year”
November 19, 2024 08:02 ET | BioTech Breakthrough
LOS ANGELES, Nov. 19, 2024 (GLOBE NEWSWIRE) -- BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology...
BIO Protocol and Binance Labs
Binance Labs Invests in BIO Protocol to Accelerate Decentralized Science (DeSci) Funding
November 08, 2024 10:00 ET | BIO Protocol
Main Takeaways: Binance Labs has invested in BIO Protocol, a pioneering protocol transforming the way early-stage scientific research is financed and commercialized using blockchain technology.At...
tiziana-logo.png
Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data
November 01, 2024 13:00 ET | Tiziana Life Sciences Ltd.
NEW YORK, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
cmi_logo.png
[Latest] Global Trimethylhydroquinone Market Size/Share Worth USD 998.6 Million by 2033 at a 4.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
October 10, 2024 02:30 ET | Custom Market Insights
Austin, TX, USA, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Trimethylhydroquinone Market Size, Trends and Insights By Type (Pharmaceutical...
cmi_logo.png
[Latest] Global Protein Purification and Isolation Market Size/Share Worth USD 22,003.8 Million by 2033 at a 9.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
June 10, 2024 09:00 ET | Custom Market Insights
Austin, TX, USA, June 10, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Protein Purification and Isolation Market Size, Trends and Insights By Product...
enteralogo.png
Entera Bio Reports Phase 1 Clinical Data of First-in-Class, Oral PTH(1-34) Peptide Candidate (EB612) for Patients with Hypoparathyroidism at ENDO 2024
June 03, 2024 08:00 ET | Entera Bio Ltd.
JERUSALEM, June 03, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and small therapeutic proteins,...
SAB_Logo.png
SAB Biotherapeutics Announces Q1 2024 Financial Results and Provides Company Updates
May 20, 2024 17:45 ET | SAB Biotherapeutics, Inc.
SAB Biotherapeutics Announces Q1 2024 Financial Results